Literature DB >> 18431647

Crystal structure determination of new antimitotic agent bis(p-fluorobenzyl)trisulfide.

Haoyun An1, Xiurong Hu, Jianming Gu, Linshen Chen, Weiming Xu, Xiaopeng Mo, Wanhong Xu, Xiaobo Wang, Xiao Xu.   

Abstract

The purpose of this research was to investigate the physical characteristics and crystalline structure of bis(p-fluorobenzyl)trisulfide, a new anti-tumor agent. Methods used included X-ray single crystal diffraction, X-ray powder diffraction (XRPD), Fourier-transform infrared (FT-IR) spectroscopy, differential scanning calorimetric (DSC) and thermogravimetric (TG) analyses. The findings obtained with X-ray single crystal diffraction showed that a monoclinic unit cell was a = 12.266(1) A, b = 4.7757(4) A, c = 25.510(1) A, beta = 104.25(1) degrees ; cell volume = 1,448.4(2) A(3), Z = 4, and space group C2/c. The XRPD studies of the four crystalline samples, obtained by recrystallization from four different solvents, indicated that they had the same diffraction patterns. The diffraction pattern stimulated from the crystal structure data is in excellent agreement with the experimental results. In addition, the identical FT-IR spectra of the four crystalline samples revealed absorption bands corresponding to S-S and C-S stretching as well as the characteristic aromatic substitution. Five percent weight loss at 163.3 degrees C was observed when TG was used to study the decomposition process in the temperature range of 20-200 degrees C. DSC also allowed for the determination of onset temperatures at 60.4(1)-60.7(3) degrees C and peak temperatures at 62.1(3)-62.4(3) degrees C for the four crystalline samples studied. The results verified that the single crystal structure shared the same crystal form with the four crystalline samples investigated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18431647      PMCID: PMC2976933          DOI: 10.1208/s12249-008-9081-5

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  15 in total

Review 1.  Anticancer drug design based on plant-derived natural products.

Authors:  K H Lee
Journal:  J Biomed Sci       Date:  1999 Jul-Aug       Impact factor: 8.410

2.  Structural characterization of three crystalline modifications of telmisartan by single crystal and high-resolution X-ray powder diffraction.

Authors:  R E Dinnebier; P Sieger; H Nar; K Shankland; W I David
Journal:  J Pharm Sci       Date:  2000-11       Impact factor: 3.534

Review 3.  Natural products as sources of new drugs over the period 1981-2002.

Authors:  David J Newman; Gordon M Cragg; Kenneth M Snader
Journal:  J Nat Prod       Date:  2003-07       Impact factor: 4.050

Review 4.  Antimicrobial and chemopreventive properties of herbs and spices.

Authors:  P K Lai; J Roy
Journal:  Curr Med Chem       Date:  2004-06       Impact factor: 4.530

Review 5.  Drugs as materials: valuing physical form in drug discovery.

Authors:  Colin R Gardner; Christopher T Walsh; Orn Almarsson
Journal:  Nat Rev Drug Discov       Date:  2004-11       Impact factor: 84.694

6.  Cell cycle modulatory and apoptotic effects of plant-derived anticancer drugs in clinical use or development.

Authors:  Nadine Darwiche; Sara El-Banna; Hala Gali-Muhtasib
Journal:  Expert Opin Drug Discov       Date:  2007-03       Impact factor: 6.098

7.  Cancer multidrug resistance: a review of recent drug discovery research.

Authors:  Mordechai Liscovitch; Yaakov Lavie
Journal:  IDrugs       Date:  2002-04

8.  A novel taxane with improved tolerability and therapeutic activity in a panel of human tumor xenografts.

Authors:  D Polizzi; G Pratesi; M Tortoreto; R Supino; A Riva; E Bombardelli; F Zunino
Journal:  Cancer Res       Date:  1999-03-01       Impact factor: 12.701

Review 9.  A tale of two tumor targets: topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy.

Authors:  Gordon M Cragg; David J Newman
Journal:  J Nat Prod       Date:  2004-02       Impact factor: 4.050

10.  Antitumour and antiangiogenic effects of IDN 5390, a novel C-seco taxane, in a paclitaxel-resistant human ovarian tumour xenograft.

Authors:  G Petrangolini; G Cassinelli; G Pratesi; M Tortoreto; E Favini; R Supino; C Lanzi; S Belluco; F Zunino
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

View more
  1 in total

1.  Versatile synthesis and biological evaluation of novel 3'-fluorinated purine nucleosides.

Authors:  Hang Ren; Haoyun An; Paul J Hatala; William C Stevens; Jingchao Tao; Baicheng He
Journal:  Beilstein J Org Chem       Date:  2015-12-09       Impact factor: 2.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.